Immunic, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
IMUX on Nasdaq
Location
1200 Avenue Of The Americas, Suite 200, New York, United States

Insiders trading volume in the past year

Immunic, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel Vitt President and CEO, Director $512K +$18.3K +3.71% Mar 4, 2024
Glenn Whaley Chief Financial Officer $44.6K Mar 4, 2024
Barclay Phillips Director Jun 11, 2024
Duane Nash Executive Chairman, Director Mar 4, 2024
Jan van den Bossche Director Jun 15, 2022
Joerg Neermann Director Jun 11, 2024
Andreas Muehler Chief Medical Officer Mar 4, 2024
Monika Maria Toernsen Director Jun 11, 2024
Richard A. Rudick Director Jun 11, 2024
Tamar Howson Director Jun 11, 2024
Simona Skerjanec Director Jul 22, 2024
Vincent Ossipow Director Jun 15, 2022
Jason Tardio President and COO Jul 12, 2024

Recent Insider Transactions by Companies or Individuals for Immunic, Inc.

Insider Symbol Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership